Insilico Medicine Reports Positive Phase IIa Results For a First-in-Class Drug Treatment For Idiopathic Pulmonary Fibrosis Designed by Generative AI September 26, 2024
AI-designed TNIK Inhibitors Could Treat a Range of Aging-Related Diseases, From Fibrosis to Alzheimer’s. May 29, 2024
Insilico Medicine Reports Positive Phase IIa Results For a First-in-Class Drug Treatment For Idiopathic Pulmonary Fibrosis Designed by Generative AI September 26, 2024
AI-designed TNIK Inhibitors Could Treat a Range of Aging-Related Diseases, From Fibrosis to Alzheimer’s. May 29, 2024
